Rheumatoid Arthritis News

• Dermatologists Share Vitiligo Breakthrough News With Patients First-ever treatment for repigmentation is safe, effective, and comes in a topical cream.
  Medscape Medical News, August 05, 2022
• Alert Ustekinumab Becomes Second Biologic Approved for PsA in Kids The approval is based on an extrapolation of data from adult trials in active psoriatic arthritis and adult and pediatric studies in moderate to severe plaque psoriasis.
  FDA Approvals, August 02, 2022
• TNF Inhibitor Use for RA Shows Beneficial Effect in Pregnancy Women who treated their rheumatoid arthritis during pregnancy with a tumor necrosis factor inhibitor gave birth to infants with higher birth weights, without a higher risk of adverse outcomes.
  Medscape Medical News, July 28, 2022
• GRAPPA 2022 Neural Networks Can Distinguish PsA From RA Using Only MRI Deep-learning programming can be trained to distinguish inflammatory joint diseases with reasonable accuracy.
  Medscape Medical News, July 18, 2022
• EULAR 2022 Methotrexate's Impact on COVID Vaccination: New Insights Made New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after the COVID-19 vaccine.
  Medscape Medical News, July 18, 2022
• GRAPPA 2022 Novel PsA Treatment Choice Algorithm Uses T-Cell Behavior A novel treatment algorithm for psoriatic arthritis (PsA) is being developed to provide more precise biologic choices.
  Medscape Medical News, July 18, 2022
• State Abortion Bans Prevent Women From Getting Essential Medication Annie England Noblin, a 40-year-old resident of rural Missouri, had never had a problem filling her monthly prescription for methotrexate until this week.
  Reuters Health Information, July 14, 2022
• Feds Warn Pharmacists: Don't Refuse to Provide Abortion Pills The Biden administration issued guidance to remind the nation's 60,000 retail pharmacies of their obligation under federal law to supply prescribed medications, including drugs that cause an abortion.
  WebMD Health News, July 14, 2022
• Patients Taking Methotrexate Face New Barriers Under Roe v Wade Decision Pharmacists in some parts of the country are denying access to the oral abortifacient methotrexate; White House and associations are taking steps to protect access to needed medications.
  Medscape Medical News, July 12, 2022
• Post-Zoster Vaccine Flares Not Increased in Patients With IMIDs Flares were defined as hospitalization/emergency department visits for IMIDs, steroid treatment with a short-acting oral glucocorticoid, or treatment with a parenteral glucocorticoid injection.
  Medscape Medical News, July 11, 2022
• Cohort Study Evaluates Risk of TNF Inhibitor–Induced Psoriasis The study involved an analysis of TNF inhibitor-induced psoriasis risk in 109,085 patients with RA and IBD enrolled in Danish national registries between 1995 and 2018.
  Medscape Medical News, July 11, 2022
• Acute Exacerbations Common and Often Fatal in RA-ILD Acute exacerbations are common in RA-associated interstitial lung disease and a frequent cause of mortality.
  Medscape Medical News, July 06, 2022
• Baricitinib for Alopecia Areata: Starting Patients on Treatment Physicians should be ready for questions on who should get the drug, how fast it works, and what patients should consider regarding the label's boxed warning.
  Medscape Medical News, July 01, 2022
• Post Roe, New Worries About Meds Linked to Birth Defects Physicians fear that women won't get the best treatments or will face dangerous risks.
  Medscape Medical News, June 29, 2022
• Hydroxychloroquine Risk Found in Some Older Patients With RA Hydroxychloroquine initiation in older patients with rheumatoid arthritis and heart failure was associated with an increased risk for cardiovascular events compared with methotrexate.
  Medscape Medical News, June 28, 2022
• Alert Upadacitinib Recommended for Nonradiographic AxSpA in Europe The Janus kinase inhibitor is already approved for the treatment of active ankylosing spondylitis in the European Union.
  International Approvals, June 28, 2022
• EULAR 2022 Treat-to-Target With Tapering Proves Effective in PsA, AxSpA A trial showed for the first time that disease activity-guided, treat-to-target tapering strategies in both psoriatic arthritis and axial spondyloarthritis are noninferior to those without tapering.
  Medscape Medical News, June 28, 2022
• EULAR 2022 Osteoporosis Risk Rises With Air Pollution Levels Chronic exposure to particulate matter 2.5 micrometers or larger in size at concentrations above 25 micrograms per cubic meter raised the likelihood of osteoporosis by 18%-22% in a 7-year longitudinal study.
  Medscape Medical News, June 21, 2022
• Azathioprine Discontinuation Linked to Genotype Regardless of Race Across multiple disease settings, patients with the rs2814778-CC genotype face a higher risk of stopping azathioprine due to hematopoietic toxicity and receiving lower doses of thiopurines, regardless of race, a new study suggests.
  Reuters Health Information, June 20, 2022
• EULAR 2022 Death Risk Spikes With New Onset-Depression After RA Diagnosis Developing depression after a diagnosis of rheumatoid arthritis substantially increased the risk for death over 10 years in a large Danish population study.
  Medscape Medical News, June 15, 2022